Kinnate Biopharma Inc.

KNTENASDAQHealthcare

$2.65

$-0.01(-0.38%)

Market Cap$124990960

P/E Ratio—

52W High$7.185

52W Low$1.04

Avg Volume418K

Open$2.65

Beta1.34

Overview

Kinnate Biopharma Inc.（KNTE）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

knte · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2025年4月25日

分析师评级与共识

基于过去 3 个月内 6 位华尔街分析师

Hold

6 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 6 · 买入占比: 33.3%

12 个月目标价

High

$30.00

Consensus

$30.00

+1032.1% upside

Low

$30.00

Median: $30 · Last Close: $2.65

Kinnate Biopharma Inc.（KNTE）的分析师共识为 Hold，基于过去 3 个月内 6 位华尔街分析师的评级。KNTE 的 12 个月平均目标价为 $30.00，相对当前价 $2.65 代表 +1032.1% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-10	$2.68	↑ 1.12%	$2.67	$2.69

1-day model range: $2.67–$2.69. Peak: $2.69 (+1.12%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%28%29%

6Buy

4Neutral

4Sell

RSI (14)76.2Overbought

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · KNTE · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$2.66SELL

MA 10$2.65SELL

MA 20$2.60BUY

MA 50$2.49BUY

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $KNTE · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$2.65SELL

EMA 10$2.64BUY

EMA 20$2.60BUY

EMA 50$2.52BUY

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $KNTE · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2024-02-26	Stifel	Maintains	Hold→Hold
2024-01-17	Wedbush	Maintains	Neutral→Neutral
2023-09-19	HC Wainwright & Co.	Downgrade ↓	Buy→Neutral
2023-09-19	Jefferies	Maintains	Buy→Buy
2023-09-19	Piper Sandler	Downgrade ↓	Overweight→Neutral
2023-09-19	Wedbush	Downgrade ↓	Outperform→Neutral
2023-09-18	Jefferies	Maintains	Buy→Buy
2023-09-18	Piper Sandler	Downgrade ↓	Overweight→Neutral
2023-09-18	HC Wainwright & Co.	Downgrade ↓	Buy→Neutral
2023-09-18	Wedbush	Downgrade ↓	Outperform→Neutral

Stifel2024-02-26

Maintains

Hold→Hold

Wedbush2024-01-17

Maintains

Neutral→Neutral

HC Wainwright & Co.2023-09-19

Downgrade ↓

Buy→Neutral

Jefferies2023-09-19

Maintains

Buy→Buy

Piper Sandler2023-09-19

Downgrade ↓

Overweight→Neutral

Wedbush2023-09-19

Downgrade ↓

Outperform→Neutral

Jefferies2023-09-18

Maintains

Buy→Buy

Piper Sandler2023-09-18

Downgrade ↓

Overweight→Neutral

HC Wainwright & Co.2023-09-18

Downgrade ↓

Buy→Neutral

Wedbush2023-09-18

Downgrade ↓

Outperform→Neutral

Wall Street analysts have recently issued updated ratings on Kinnate Biopharma Inc. (KNTE) stock. Of the recent 35 rating actions, 0 were upgrades and 8 were downgrades. 6 analysts currently cover KNTE.

分析师推荐趋势

Buy ratings4 → 0↓ 4

Hold ratings2 → 1↓ 1

Sell ratings0 → 0

KNTE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$0M

Revenue Next Year

$0M

EPS This Year

$-1.04

EPS Next Year

$-0.87

↓ 16.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast KNTE EPS of $-1.04 for the current fiscal year, based on estimates from 4 analysts. The KNTE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

KNTE 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KNTE 的共识目标价为 $30.00（+1032.1% 上行空间），分析师共识为 Hold。

KNTE 的短期预测（明日）为 $2.68（+1.12%）。

Kinnate Biopharma Inc. 在 NASDAQ 上市，代码 KNTE。KNTE 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 33% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

KNTE 预测 · 8 个问题

根据 6 位华尔街分析师，KNTE 的 12 个月平均目标价为 $30.00，最高 $30.00、最低 $30.00。若有图表，中位目标价可在上方查看。相对当前价 $2.65，隐含约 +1032.1% 的上行空间。

KNTE 目标价KNTE 分析师目标价KNTE 12个月目标价目标价 KNTE

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.